CXCR7 correlates with the differentiation of hepatocellular carcinoma and suppresses HNF4α expression through the ERK pathway

Xue,Tong-Chun; Jia,Qing-An; Bu,Yang; Chen,Rong-Xin; Cui,Jie‑Feng; Tang,Zhao-You; Ye,Sheng-Long

doi:10.3892/or.2014.3501

CXCR7 correlates with the differentiation of hepatocellular carcinoma and suppresses HNF4α expression through the ERK pathway

Authors:
- Tong-Chun Xue
- Qing-An Jia
- Yang Bu
- Rong-Xin Chen
- Jie‑Feng Cui
- Zhao-You Tang
- Sheng-Long Ye
View Affiliations

Affiliations: Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, P.R. China
Published online on: September 19, 2014 https://doi.org/10.3892/or.2014.3501
Pages: 2387-2396

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Hepatocellular carcinoma (HCC) is a malignancy with dysregulated differentiation. However, effective differentiation therapy for HCC is lacking. Previous evidence suggests that CXCR7 is associated with the differentiation of embryonic stem cells. Here, we evaluated the potential role of CXCR7 in the differentiation of HCC. In HCC cell lines, the expression of cancer stem cell-related markers was assessed by flow cytometry and confirmed by western blot and immunofluorescence analyses. Dimethyl sulfoxide, oncostatin M and dexamethasone were used to induce the differentiation of HCC. Immunohistochemical assay was performed on a tissue microarray based on 112 HCC cases that received hepatectomy. Ligand activation, inhibition assays and RNA interference were used to analyze the regulation of hepatocyte nuclear factor 4α (HNF4α) by the CXCR7 pathway. Huh7 and HCCLM3 cell lines were screened for differentiation induction based on biomarkers of hepatic cancer stem cells. CXCR7 was found to be closely associated with the differentiation of HCC, and an inverse expression trend between CXCR7 and HNF4α was found upon induced differentiation. Clinically, high CXCR7 expression was negatively correlated with HNF4α expression in patients with relatively well-differentiated HCC. Moreover, high CXCR7 expression was correlated with poor overall survival and accelerated post-resection metastasis in HCC with a low HNF4α level. Mechanistically, CXCR7 signaling inhibited HNF4α through extracellular regulated protein kinase (ERK) activation, which was inhibited by U0126, an inhibitor of MAPK/ERK kinases 1 and 2. Knockdown of CXCR7 further confirmed that CXCR7 signaling can regulate HNF4α expression. Taken together, our findings indicate that CXCR7 participates in the differentiation of HCC by regulating HNF4α. The CXCR7-ERK-HNF4α cascade represents a new target for the differentiation therapy of HCC.

View Figures

View References

1	Ker CG, Chen HY, Chen KS, et al: Clinical significance of cell differentiation in hepatocellular carcinoma. Hepatogastroenterology. 50:475–479. 2003.PubMed/NCBI
2	Nowak D, Stewart D and Koeffler HP: Differentiation therapy of leukemia: 3 decades of development. Blood. 113:3655–3665. 2009. View Article : Google Scholar : PubMed/NCBI
3	Zhang L, Sun H, Zhao F, et al: BMP4 administration induces differentiation of CD133⁺ hepatic cancer stem cells, blocking their contributions to hepatocellular carcinoma. Cancer Res. 72:4276–4285. 2012.PubMed/NCBI
4	Yin C, Lin Y, Zhang X, et al: Differentiation therapy of hepatocellular carcinoma in mice with recombinant adenovirus carrying hepatocyte nuclear factor-4alpha gene. Hepatology. 48:1528–1539. 2008. View Article : Google Scholar
5	Ishiyama T, Kano J, Minami Y, Iijima T, Morishita Y and Noguchi M: Expression of HNFs and C/EBP alpha is correlated with immunocytochemical differentiation of cell lines derived from human hepatocellular carcinomas, hepatoblastomas and immortalized hepatocytes. Cancer Sci. 94:757–763. 2003. View Article : Google Scholar
6	Costa RH, Kalinichenko VV, Holterman AX and Wang X: Transcription factors in liver development, differentiation, and regeneration. Hepatology. 38:1331–1347. 2003. View Article : Google Scholar : PubMed/NCBI
7	DeLaForest A, Nagaoka M, Si-Tayeb K, et al: HNF4A is essential for specification of hepatic progenitors from human pluripotent stem cells. Development. 138:4143–4153. 2011. View Article : Google Scholar : PubMed/NCBI
8	Walesky C, Edwards G, Borude P, et al: Hepatocyte nuclear factor 4 alpha deletion promotes diethylnitrosamine-induced hepatocellular carcinoma in mice. Hepatology. 57:2480–2490. 2013. View Article : Google Scholar
9	Ning BF, Ding J, Yin C, et al: Hepatocyte nuclear factor 4 alpha suppresses the development of hepatocellular carcinoma. Cancer Res. 70:7640–7651. 2010. View Article : Google Scholar : PubMed/NCBI
10	Balabanian K, Lagane B, Infantino S, et al: The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J Biol Chem. 280:35760–35766. 2005. View Article : Google Scholar : PubMed/NCBI
11	Burns JM, Summers BC, Wang Y, et al: A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J Exp Med. 203:2201–2213. 2006. View Article : Google Scholar : PubMed/NCBI
12	Rajagopal S, Kim J, Ahn S, et al: Beta-arrestin - but not G protein-mediated signaling by the ‘decoy’ receptor CXCR7. Proc Natl Acad Sci USA. 107:628–632. 2010.
13	Yu S, Crawford D, Tsuchihashi T, Behrens TW and Srivastava D: The chemokine receptor CXCR7 functions to regulate cardiac valve remodeling. Dev Dyn. 240:384–393. 2011. View Article : Google Scholar : PubMed/NCBI
14	Maksym RB, Tarnowski M, Grymula K, et al: The role of stromal-derived factor-1-CXCR7 axis in development and cancer. Eur J Pharmacol. 625:31–40. 2009. View Article : Google Scholar : PubMed/NCBI
15	Xue TC, Chen RX, Han D, et al: Down-regulation of CXCR7 inhibits the growth and lung metastasis of human hepatocellular carcinoma cells with highly metastatic potential. Exp Ther Med. 3:117–123. 2012.PubMed/NCBI
16	Xue TC, Chen RX, Ren ZG, Zou JH, Tang ZY and Ye SL: Transmembrane receptor CXCR7 increases the risk of extrahepatic metastasis of relatively well-differentiated hepatocellular carcinoma through upregulation of osteopontin. Oncol Rep. 30:105–110. 2013.
17	Pasini D, Bracken AP, Hansen JB, Capillo M and Helin K: The polycomb group protein Suz12 is required for embryonic stem cell differentiation. Mol Cell Biol. 27:3769–3779. 2007. View Article : Google Scholar : PubMed/NCBI
18	Dalby B, Cates S, Harris A, et al: Advanced transfection with Lipofectamine 2000 reagent: primary neurons, siRNA, and high-throughput applications. Methods. 33:95–103. 2004. View Article : Google Scholar : PubMed/NCBI
19	Sun HC, Zhuang PY, Qin LX, et al: Incidence and prognostic values of lymph node metastasis in operable hepatocellular carcinoma and evaluation of routine complete lymphadenectomy. J Surg Oncol. 96:37–45. 2007. View Article : Google Scholar : PubMed/NCBI
20	Simon R, Mirlacher M and Sauter G: Immunohistochemical analysis of tissue microarrays. Methods Mol Biol. 664:113–126. 2010. View Article : Google Scholar : PubMed/NCBI
21	Lugli A, Spichtin H, Maurer R, et al: EphB2 expression across 138 human tumor types in a tissue microarray: high levels of expression in gastrointestinal cancers. Clin Cancer Res. 11:6450–6458. 2005. View Article : Google Scholar
22	Liu LL, Fu D, Ma Y and Shen XZ: The power and the promise of liver cancer stem cell markers. Stem Cells Dev. 20:2023–2030. 2011. View Article : Google Scholar : PubMed/NCBI
23	Lee TK, Castilho A, Cheung VC, Tang KH, Ma S and Ng IO: CD24(+) liver tumor-initiating cells drive self-renewal and tumor initiation through STAT3-mediated NANOG regulation. Cell Stem Cell. 9:50–63. 2011. View Article : Google Scholar : PubMed/NCBI
24	Yang ZF, Ho DW, Ng MN, et al: Significance of CD90⁺ cancer stem cells in human liver cancer. Cancer Cell. 13:153–166. 2008.
25	Yamashita T, Honda M, Nio K, et al: Oncostatin m renders epithelial cell adhesion molecule-positive liver cancer stem cells sensitive to 5- Fluorouracil by inducing hepatocytic differentiation. Cancer Res. 70:4687–4697. 2010. View Article : Google Scholar
26	Hay DC, Zhao D, Fletcher J, et al: Efficient differentiation of hepatocytes from human embryonic stem cells exhibiting markers recapitulating liver development in vivo. Stem Cells. 26:894–902. 2008. View Article : Google Scholar : PubMed/NCBI
27	Hatzis P, Kyrmizi I and Talianidis I: Mitogen-activated protein kinase-mediated disruption of enhancer-promoter communication inhibits hepatocyte nuclear factor 4alpha expression. Mol Cell Biol. 26:7017–7029. 2006. View Article : Google Scholar
28	Zhao Z, Hong W, Zeng Z, et al: Mucroporin-M1 inhibits hepatitis B virus replication by activating the mitogen-activated protein kinase (MAPK) pathway and down-regulating HNF4alpha in vitro and in vivo. J Biol Chem. 287:30181–30190. 2012. View Article : Google Scholar : PubMed/NCBI
29	Shenoy SK and Lefkowitz RJ: β-Arrestin-mediated receptor trafficking and signal transduction. Trends Pharmacol Sci. 32:521–533. 2011.
30	Basson MA: Signaling in cell differentiation and morphogenesis. Cold Spring Harb Perspect Biol. 4:2012.pii: a008151. View Article : Google Scholar
31	Yokoyama A, Katsura S, Ito R, et al: Multiple post-translational modifications in hepatocyte nuclear factor 4α. Biochem Biophys Res Commun. 410:749–753. 2011.
32	Hanse EA, Mashek DG, Becker JR, et al: Cyclin D1 inhibits hepatic lipogenesis via repression of carbohydrate response element binding protein and hepatocyte nuclear factor 4α. Cell Cycle. 11:2681–2690. 2012.PubMed/NCBI
33	Sakamaki J, Daitoku H, Kaneko Y, Hagiwara A, Ueno K and Fukamizu A: GSK3β regulates gluconeogenic gene expression through HNF4α and FOXO1. J Recept Signal Transduct Res. 32:96–101. 2012.
34	Cozzolino AM, Alonzi T, Santangelo L, et al: TGFβ overrides HNF4α tumor suppressing activity through GSK3β inactivation: implication for hepatocellular carcinoma gene therapy. J Hepatol. 58:65–72. 2013.
35	Colletti M, Cicchini C, Conigliaro A, et al: Convergence of Wnt signaling on the HNF4alpha-driven transcription in controlling liver zonation. Gastroenterology. 137:660–672. 2009. View Article : Google Scholar : PubMed/NCBI